日立インスファーマ、オムニコムとの提携により、日本で「eクリニカル」ソリューションを提供
26. Dezember 2018 16:48 ET
|
OmniComm Systems Inc.
フロリダ州フォートローダーデール発, Dec. 27, 2018 (GLOBE NEWSWIRE) -- 臨床データ管理テクノロジーの世界的なリーディングプロバイダーである、オムニコム･システムズ (OmniComm Systems, Inc.、OTCQX: OMCM) は、日立製作所グループの企業である日立インスファーマ (Hitachi Inspharma)...
Hitachi Inspharma Partners With OmniComm to Offer eClinical Solutions in Japan
26. Dezember 2018 08:00 ET
|
OmniComm Systems Inc.
FORT LAUDERDALE, Fla., Dec. 26, 2018 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data management technology, announced a partnership with Hitachi...
Surrey Clinical Research Centre Signs Five-Year Contract Renewal With OmniComm Systems
13. Dezember 2018 09:00 ET
|
OmniComm Systems Inc.
Leading Academic Research Centre Continues its Collaboration With OmniComm’s Promasys® EDC Fort Lauderdale, FL, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Surrey Clinical Research Centre, a core...
International Biopharmaceutical Company Selects OmniComm’s TrialMaster® EDC for Multi-Study Cancer Research
27. November 2018 09:00 ET
|
OmniComm Systems Inc.
FORT LAUDERDALE, Fla., Nov. 27, 2018 (GLOBE NEWSWIRE) -- An international biopharmaceutical company has signed a multiyear agreement with OmniComm Systems, Inc. (OTCQX: OMCM), a leading global...
OmniComm Systems, Inc. Reports Financial Results for the Year-to-Date and Quarter Ending September 30, 2018
13. November 2018 16:25 ET
|
OmniComm Systems Inc.
FORT LAUDERDALE, Fla., Nov. 13, 2018 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, today announced financial...
OmniComm Attracts Industry Leaders for the 8th Annual Innovation Forum
07. November 2018 09:00 ET
|
OmniComm Systems Inc.
Fort Lauderdale, FL, Nov. 07, 2018 (GLOBE NEWSWIRE) -- The latest advancements in clinical data management, analytics, automated medical coding and randomization claimed the spotlight at the 8th...
Global CRO Signs Seven-Year TrialOne® Agreement With OmniComm Systems
17. Oktober 2018 09:00 ET
|
OmniComm Systems Inc.
New agreement expands commitment to TrialOne for early phase studies Fort Lauderdale, FL, Oct. 17, 2018 (GLOBE NEWSWIRE) -- A global provider of drug development and commercialization...
Major Cancer Research Center Signs New $3.5 Million, Multiyear Commitment to OmniComm’s TrialMaster® EDC
11. Oktober 2018 09:00 ET
|
OmniComm Systems Inc.
Fort Lauderdale, Fla., Oct. 11, 2018 (GLOBE NEWSWIRE) -- With a longstanding dedication to the development of patient-centric cancer therapies, a major clinical research center has extended its...
Sorrento Therapeutics Selects OmniComm’s TrialMaster® EDC for Cancer Research
20. September 2018 09:00 ET
|
OmniComm Systems Inc.
Fort Lauderdale, FL, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE), a clinical stage, antibody-centric, biopharmaceutical company developing new therapies to turn...
Global Contract Research Organization Announces $7.8 Million Extension Agreement for OmniComm’s TrialOne®
30. August 2018 09:00 ET
|
OmniComm Systems Inc.
FORT LAUDERDALE, Fla., Aug. 30, 2018 (GLOBE NEWSWIRE) -- A major full-service, global contract research organization (CRO) has expanded its existing partnership with OmniComm Systems, Inc. (OTCQX:...